Iron deficiency anemia

Last updated: November 01, 2022

Iron deficiency anemia

PGreen

PGreen

Cell-cell junctions
Marfan syndrome
Cellular structure and function
Development of the renal system
Mitosis and meiosis
Colorectal polyps and cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Angina pectoris
Aortic valve disease
Coarctation of the aorta
Heart failure
Pneumonia
Tetralogy of Fallot
Shock
Mitral valve disease
Pericarditis and pericardial effusion
Pleural effusion
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Pelvic inflammatory disease
Testosterone
Polycystic ovary syndrome
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Thyroid hormones
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Selective permeability of the cell membrane
Cell cycle
Free radicals and cellular injury
Autosomal trisomies: Pathology review
Breast cancer: Pathology review
Hypertension: Pathology review
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Peripheral artery disease
Pulmonary edema
Restrictive lung diseases
Stroke volume, ejection fraction, and cardiac output
Ventilation-perfusion ratios and V/Q mismatch
Cranial nerves
Migraine
Myasthenia gravis
Abnormal uterine bleeding: Clinical
Neisseria gonorrhoeae
Primary adrenal insufficiency
Benign prostatic hyperplasia
Hodgkin lymphoma
Introduction to the immune system
Celiac disease
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid antagonists
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Vitamin B12 deficiency
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Adrenergic antagonists: Beta blockers
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class III antiarrhythmics: Potassium channel blockers
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Vaccinations
Anthelmintic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Anti-parkinson medications
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Headaches: Clinical
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus
Pediatric infectious rashes: Clinical

Transcript

Watch video only

Anemia is a condition where there’s a decrease in the number of healthy red blood cells, or RBCs, in the body.

So, iron deficiency anemia means anemia caused by a deficiency in iron.

Iron deficiency anemia is also the most common type of anemia worldwide.

If we take a close look at our red blood cells, we’ll notice that they’re loaded with millions of copies of the same exact protein called hemoglobin, which binds to oxygen and turns our blood cells into little oxygen transporters, and basically allow us to move oxygen to all the tissues in our body.

If we take an even closer look at those hemoglobin proteins, we’ll find that they’re made of four heme molecules, which have, right in the middle, iron.

This iron molecule is what binds to oxygen, so each hemoglobin molecule can bind four molecules of oxygen.

In addition, iron is also an important part of proteins like myoglobin, which delivers and stores oxygen in muscles; and mitochondrial enzymes like cytochrome oxidase, which help generate ATP.

Normally, when a red blood cell dies, some iron is recycled from it.

But, we also lose about 1 milligram of iron every day - some through the sweat, some in shedded skin cells, and some in shedded cells in the gastrointestinal tract, which get out of the body through feces.

But most of us take in 10-20 mg of dietary iron every day, and absorb about 10% of it, or about 1 or 2 milligrams - so it all evens out at the end of the day!

Now, our diet contains two forms of iron.

The first is heme iron, or iron bound to hemoglobin or myoglobin, which comes from animal products like meat.

Heme iron is in the ferrous, or Fe2+, state.

The other form is non-heme iron, which is free iron molecules in the ferric, or Fe3+, state.

Non-heme iron comes from plant based foods like spinach and beans.

Now, when food is broken down in the stomach, iron is released.

Heme iron is absorbed directly into the duodenal cells, where it is broken down to release Fe2+ molecules.

Non-heme iron, however, needs to be reduced to heme iron first.

So the stomach’s hydrochloric acid activates a group of enzymes in the duodenal cells, collectively called ferri-reductase, which live up to their name by reducing non-heme iron to Fe2+ molecules.

Fe2+ molecules then bind to a protein in the duodenal cells called ferritin, which temporarily stores the iron.

And when iron is needed in the body, some Fe2+ molecules are released from ferritin and transported into the blood, where the enzyme hephaestin converts them back to the Fe3+ state.

Fe3+ molecules then bind to an iron transport protein called transferrin that carries iron to various target tissues and releases them there.

Fe3+ enters these various tissue cells, where there’s some more ferritin that can store them for future use.

Iron deficiency anemia can develop as a result of four main causes: decreased intake, decreased absorption, increased demand, and increased loss.

Decreased intake is the most common cause of iron deficiency anemia worldwide, and it occurs in infants, because breast milk is surprisingly low in iron; and vegetarians, whose iron intake is mostly nonheme iron, which is harder to absorb.

Decreased absorption can also occur when there’s a decrease in stomach acid production, like after a gastrectomy, where a part of the stomach is surgically removed.

Finally, decreased absorption may occur with inflammatory bowel disease or celiac disease, both of which cause inflammation and destruction of duodenal cells.

Next up, increased demand can occur in children and adolescents due to rapid growth and increase in blood volume, which requires them to make more hemoglobin.

Alternatively, it may occur during pregnancy, due to increased iron requirements for fetal development.

Finally, increased iron loss generally occurs in people with chronic slow bleeding, because iron is lost along red blood cells.

This includes females with frequent or heavy menstruation or people with bleeding gastric ulcers, and, most importantly, elderly males with colon cancer, because the tumor can bleed and cause anemia.

In fact, the first symptom of colon cancer is often iron deficiency anemia.

Sources

  1. "Robbins and Cotran Pathologic Basis of Disease, Professional Edition E-Book" Elsevier Health Sciences (2014)
  2. "Iron-Deficiency Anemia" National Heart, Lung, and Blood Institute
  3. "Blood and Bone Marrow Pathology" Churchill Livingstone (2010)
  4. "Iron Deficiency Anemia" Medical Clinics of North America (2017)
  5. "Haematology" Churchill Livingstone (2012)
  6. "Iron-Deficiency Anemia" New England Journal of Medicine (2015)
  7. "Iron deficiency anemia" PubMed (2007)